Publication:

Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer

Date

Date

Date
2016
Journal Article
Published version

Citations

Citation copied

Harter, P., du Bois, A., Mahner, S., Pfisterer, J., Ortmann, O., Marth, C., Fink, D., Hilpert, F., Wagner, U., & Sehouli, J. (2016). Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer. Geburtshilfe Und Frauenheilkunde, 76(2), 147–149. https://doi.org/10.1055/s-0035-1568169

Abstract

Abstract

Abstract

The AGO Kommission Ovar already published a statement in 2013, warning about the uncritical use of hyperthermic intraperitoneal chemotherapy (HIPEC) outside controlled studies. This statement has now been updated after the most recent literature was reviewed by AGO Kommission Ovar, the AGO Study Group, NOGGO, AGO Austria and AGO Switzerland. The authors conclude that HIPEC remains experimental. Its use is not recommended and should be rejected outside of prospective controlled trials. Bereits in 2013 wurde eine Stellungnahme der AGO K

Metrics

Downloads

3 since deposited on 2017-02-21
1last week
Acq. date: 2025-11-12

Views

1 since deposited on 2017-02-21
Acq. date: 2025-11-12

Additional indexing

Other titles

Other titles

Other titles
Statement der AGO Kommission Ovar, AGO Studiengruppe, NOGGO, AGO Österreich und AGO Schweiz zum Einsatz der hyperthermen intraperitonealen Chemotherapie (HIPEC) bei Ovarialkarzinom

Creators (Authors)

  • Harter, P
    affiliation.icon.alt
  • du Bois, A
    affiliation.icon.alt
  • Mahner, S
    affiliation.icon.alt
  • Pfisterer, J
    affiliation.icon.alt
  • Ortmann, O
    affiliation.icon.alt
  • Marth, C
    affiliation.icon.alt
  • Fink, D
    affiliation.icon.alt
  • Hilpert, F
    affiliation.icon.alt
  • Wagner, U
    affiliation.icon.alt
  • Sehouli, J
    affiliation.icon.alt

Journal/Series Title

Journal/Series Title

Journal/Series Title

Volume

Volume

Volume
76

Number

Number

Number
2

Page range/Item number

Page range/Item number

Page range/Item number
147

Page end

Page end

Page end
149

Item Type

Item Type

Item Type
Journal Article

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Dewey Decimal Classifikation

Language

Language

Language
English

Publication date

Publication date

Publication date
2016

Date available

Date available

Date available
2017-02-21

Publisher

Publisher

Publisher

ISSN or e-ISSN

ISSN or e-ISSN

ISSN or e-ISSN
0016-5751

OA Status

OA Status

OA Status
Hybrid

Free Access at

Free Access at

Free Access at
Pubmed ID

PubMed ID

PubMed ID

PubMed ID

Metrics

Downloads

3 since deposited on 2017-02-21
1last week
Acq. date: 2025-11-12

Views

1 since deposited on 2017-02-21
Acq. date: 2025-11-12

Citations

Citation copied

Harter, P., du Bois, A., Mahner, S., Pfisterer, J., Ortmann, O., Marth, C., Fink, D., Hilpert, F., Wagner, U., & Sehouli, J. (2016). Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer. Geburtshilfe Und Frauenheilkunde, 76(2), 147–149. https://doi.org/10.1055/s-0035-1568169

Hybrid Open Access
Loading...
Thumbnail Image

Files

Files

Files
Files available to download:1

Files

Files

Files
Files available to download:1
Loading...
Thumbnail Image